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1. Introduction 
NAD-specific isocitrate dehydrogenase (EC 
1 .1.1.41) from bovine and porcine heart is an allo- 
steric enzyme consisting of 8 subunits with nearly 
identical molecular weights [I]. Recent studies sug- 
gest that these subunits are composed of 2 [2] or 4 
[3] different polypeptide chains. While ADP is a posi- 
tive modifier and has the effect of aggregating the 
enzyme into higher molecular forms 141, reduced 
pyridine nucleotides inhibit the catalytic activity 
[5,6]. It has been shown [7] that the enzyme in its 
octameric form has 4 NADH binding sites. The fluo- 
rescence of NADH was enhanced ‘lo-fold on binding 
to one of these sites. 
Although the structural requirements for NAD* 
cosubstrate and ADP activator have been ~vestigated 
in detail by using various analogues [8], the NADH 
inhibitor binding sites have not been examined. We 
report here the interaction of dihydronicotinamide 
formycin dinucleotide (NFDH) with the enzyme 
from bovine heart. This NADH analogue contains, 
instead of adenosine, a formycin portion which is 
fluorescent. Thus NFDH is a double fluorophor, con- 
taining two fluorescent moieties, the 7aminopyrazo- 
lopyrimidine and dihydronicotinamide bases (fig.1). 
Its fluorescence behavior in the presence of NAD- 
specific isocitrate dehydrogenase is reported. 
2. Materials and methods 
NAD-specific isocitrate dehydrogenase was iso- 
lated from bovine heart [l] and had spec. act. 28 
unitslmg protein as assayed under the standard 
conditions in [9]. The concentration of the purified 
enzyme was estimated from the extinction coeffi- 
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Fig.1. NFDH = dihydronicotinamide formycin dinucleotide 
cient EzT8 (0.1%) = 0.53 cm-’ [9] and mol. wt 
320 000 [ 1 ]. Yeast alcohol dehydrogenase was 
obtained from Worthington Biochemical Corp. and 
snake venom phosphodiesterase from Boehringer- 
Mannheim. 
Formycin was purchased from Meiji Seika Kaisha 
Ltd., Tokyo. Nicot~amide fo~yc~ d~ucleotide 
(NFD+) was synthesized according to [IO]. NFDH 
was prepared by the reduction of NFD’ in the pres- 
ence of yeast alcohol dehydrogenase and purified on 
a column of DEAEcellulose with a O-O.3 M ammo- 
nium acetate gradient (pH 8.5) Ill]. 
All spectrophotometric and fluorometric measure- 
ments were carried out in 0.17 M sodium N-2- 
hydroxyethylpiperazine&‘-2-ethanesulfonate (Na- 
Hepes) (pH 7.2), 25°C. NFDH inhibition kinetics 
were measured in 0.2 ml final vol. containing 1 .l mM 
manganese isocitrate, 0.17 M Na-Hepes (pH 7.2) 
varying concentrations of NAD’ and fixed amounts 
of NFDH and isocitrate dehydrogenase. The rate of 
A340 increase was monitored on a Cary 14 spectro- 
photometer. 
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3. Results and discussion 
3.1. Spectral characteristics of NFDH 
The ultraviolet absorption spectrum of NFDH 
shows characteristics of both the formycin moiety 
with a maximum at 295 nm and shoulders at 305 and 
320 nm [ 121 and the dihydronicotinamide moiety 
with a maximum -340 nm (fig.2A). Fluorescence 
spectrum of the compound excited at 290 nm reveals 
the formycin emission band at 340 nm and the 
reduced nicotinamide band at -460 nm. The latter 
emission may be due to both direct absorption of 
light by the dihydronicotinamide base and energy 
transfer from 7-aminopyrazolopyrimidine base. 
That energy is transferred between the two bases is 
evident from the excitation spectrum monitored at 
460 nm. When the molecule was hydrolyzed by snake 
venom phosphodiesterase, both the 295 nm shoulder 
of the excitation spectrum (monitored at 460 nm) 
and the emission band at 460 nm (excited at 290 nm) 
WAVELENGTH (NM) 
Fig.2. (A) Absorption and fluorescence spectra of NFDH. 
The absorption spectrum (-) was measured in 0.17 M 
Na-Hepes (pH 7.2) at 25°C. The emission spectrum ( . . . ) 
was measured in the same buffer excited at 290 nm. (B) Flu- 
orescence spectrum of NFDH after treatment with snake 
venom phosphodiesterase. The excitation spectra were moni- 
tored at 460 nm before (-) and after (-b-) treatment. 
The emission spectrum ( . . . ) was excited at 290 nm after 
treatment. 
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disappeared (fig.2B). Since the excited state lifetime 
of formycin is <l ns [ 121, the energy transfer 
between the two bases probably indicates that the 
molecule exists to a certain extent in the stacked 
conformation similar to that of NAD’ and NADH 
P31. 
3.2. Inhibition of isocitrate dehydrogenase 
Since NFD’ is a cosubstrate for isocitrate dehydro- 
genase [ 141, NFDH would be expected to function 
as an allosteric inhibitor. Kinetic analysis revealed 
that NFDH was a competitive inhibitor against NAD’ 
similar to NADH [ 151. The inhibition constant of 
NFDH was found to be 3 1 PM compared to that of 
40 /Jvi for NADH obtained earlier [ 151. Whereas the 
Km for NFD’ is -2-3-times greater than that for 
NAD’, the structural differences between formycin 
and adenosine do not seem to affect the binding of 
the inhibitor to the allosteric site. That the detailed 
structures of the active site and the inhibitory allo- 
steric site are different is further supported by the 
inhibitory effect of dihydronicotinamide hypoxan- 
thine dinucleotide (deamino-NADH). While the 
replacement of adenine portion of NAD’ by hypo- 
xanthine led to loss of its cosubstrate activity [ 151, 
deamino-NADH is an inhibitor with a Kd of 0.21 mM. 
3.3. Titration of isocitrate dehydrogenase with NFDH 
As with NADH [7], the fluorescence intensity of 
NFDH (excited at 340 nm) is enhanced >20-fold and 
the emission maximum shifted from 460-430 nm 
in the presence of NAD-specific isocitrate dehydro- 
genase. This is not surprising since both molecules 
contain the dihydronicotinamide base. NFDH, 
however, contains an additional fluorophor, 7- 
amiuopyrazolopyrimidine. It would be of interest to 
learn the binding environment of the adenine ring of 
NADH by studying the fluorescence behavior of this 
particular fluorophor. Unfortunately, its excitation 
maximum at 295 nm coincided with that of the 
aromatic residues of the protein, making it very diffi- 
cult to isolate the fluorescence emitted from the base. 
However, when excited at 310 nm, where the protein 
absorption is minimal,little fluorescence was observed 
at 340 nm. This may indicate that its binding site is 
relatively less hydrophobic than that for the dihy- 
dronicotinamide ring. In 95% ethanol, the emission 
from NFDH at 340 nm is enhanced >3-fold. 
The large fluorescence enhancement of NFDH at 
430 nm in the presence of the enzyme has enabled 
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NFDH binding to isocitrate dehydrogenase as revealed by 
fluorescence titrationa 
Fig.3. NFDH fluorescence titration of NAD-specific isocitrate 
dehydrogenase. Enzyme was 1 .O GM in 0.17 M Na-Hepes 
(pH 7.2). The solution was excited at 340 nm and fluores- 
cence intensity measured at 430 nm after each addition of 
NFDH. Insert: Stockell plot of titration data. 
us to study the Kd and the number of NFDH binding 
sites under various conditions. Fig.3 shows a fluores- 
cence titration curve of a fixed concentration of 
NAD-specific isocitrate dehydrogenase with successive 
additions of NFDH. The data were analyzed by the 
equation of Stockell [ 161: 
d -2L+n 
P (e-P) 
where d is the total concentration of NFDH, e the 
total concentration of protein, p the concentration 
of NFDH bound, Kd the dissociation constant and 
n the number of NFDH binding sites. 
The results of the analysis are listed in table 1. 
In the absence of any added substrate or ADP, four 
binding sites were detected with an overall Kd of 2 .O PM. 
This is in agreement with data obtained by gel filtra- 
tion [7]. Fluorescence titration with NADH, however, 
revealed only one binding site [7]. The ability of 
NFDH to detect all 4 sites may be due to the 
characteristic absorption band of formycin. The pres- 
ence of the allosteric effector ADP did not affect the 
number of binding sites. However, the Kd was slightly 
increased, reflecting a possible change of conforma- 
tion induced by ADP. 
In the presence of saturating manganese isocitrate, 
n was increased to 8. The additional binding sites 
detected are probably those of the active sites due to 
Substances added .b 
None 4.1 
ADP (1.0 mM) 4.1 
MI (1 .O mM)C 7.6 
NAD+ (0.57 mM) 1.4 
Kd OcM)b 
2.0 
4.7 
3.8 
4.4 
a The data were obtained from titration curves as shown in 
fig.3 
b Kd and n were obtained from the slope and intercept, 
respectively, of a Stockell plot 
c The concentration of total manganese and D,L-isocitrate 
were 1.3 and 5.3 mM, respectively. The concentration of 
manganous D,L-isocitrate (MI) was calculated to be 1 .O 
mM by using the stability constant K = 1.056 mM“ of [ 171 
the formation of enzyme-substrate-product ternary 
complex. The number of active sitesloctamer of 
enzyme has not been reported. If the observation 
obtained here is such that all the NFDH binding 
sites are saturated, the enzyme would have 4 
active sites/octamer. 
NAD+ has been reported not to affect the binding 
site of NADH detected by fluorescence, but partially 
displace NADH bound to the enzyme revealed by 
ultrafiltration [7]. As shown in table 1, NAD* also 
affected the binding of NFDH. In the presence of 
0.57 mM NAD’, the number of NFDH binding sites 
detected was reduced to one which probably corre- 
sponded to that detected by NADH fluorescence. It 
thus seems that the 4 NFDH binding sites are hetero- 
geneous, as suggested in [7]. 
Although nicotinamide 1 ,@-ethenoadenine 
dinucleotide (eNAD’) is not a cosubstrate for NAD- 
specific isocitrate dehydrogenase [14]; eNADH may 
inhibit the enzyme by binding to the allosteric 
regulatory sites as in the case for deamino-NADH 
mentioned earlier. If this is the case, it would be of 
interest to compare its behavior with that observed 
here. Such experiments are currently under investiga- 
tion. 
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